“Existing structural issues mean the GST reforms alone cannot sustainably raise growth prospects over the long run,” said Makoto Tsuchiya, Senior Economist at Oxford Economics.
The seasonally adjusted HSBC India Manufacturing Purchasing Managers' Index (PMI) rose from 57.7 in September to 59.2 in October, indicating a quicker improvement in the sector's health.
Telangana’s pharma sector, with 800+ firms contributing 50% of India’s bulk drug exports, benefits from GST cuts: 30 cancer drugs now nil, all personal-use medicines at 5% rate.
Minister Ravindra announced that Prime Minister Narendra Modi will participate in a mega public meeting in Kurnool on October 16 as part of the GST campaign.
